Prediction of severe cardiovascular events by VE/Vco 2 slope versus peak Vo 2 in systolic heart failure: A meta-analysis of the published literature

American Heart Journal

Volumn 160, Issue 6, 2010, Pages 1004-1014

  Poggio, Rosana ^a,b   Arazi, Hernán Cohen ^a   Giorgi, Mariano ^a,c   Miriuka, Santiago G ^a,d  

^a FLENI   (Argentina)

^b INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^d Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ARTICLE; CARBON DIOXIDE EXCRETION; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE SEVERITY; FOLLOW UP; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; LUNG VENTILATION; META ANALYSIS; MORTALITY; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SYSTEMATIC REVIEW; SYSTOLIC HEART FAILURE; VE VCO2 SLOPE;

EID: 78650109013     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.08.037     Document Type: Review

References (39)

1. Mancini D.M., Eisen H., and Kussmaul W. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
2. Mehra M.R., Kobashigawa J., and Starling R. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006 J Heart Lung Transplant 25 2006 1024 1042
3. Robbins M., Francis G., and Pashkow F.J. Ventilatory and heart rate responses to exercise: better predictors of heart failure mortality than peak oxygen consumption Circulation 100 1999 2411 2417
4. Stelken A.M., Younis L.T., and Jennison S.H. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy J Am Coll Cardiol 27 1996 345 352
5. Arena R., Myers J., and Abella J. Development of a ventilatory classification system in patients with heart failure Circulation 115 2007 2410 2417
6. Dickstein K., Cohen-Solal A., and Filippatos G. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
7. Jessup M., Abraham W.T., and Casey D.E. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
8. Arena R., Myers J., and Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review Heart Fail Rev 13 2008 245 269
9. Tumminello G., Guazzi M., and Lancellotti P. Exercise ventilation inefficiency in heart failure: pathophysiological and clinical significance Eur Heart J 28 2007 673 678 (Pubitemid 46439224)
10. Arena R., Humphrey R., and Peberdy M.A. Prognostic ability of VE/VCO2 slope calculations using different exercise test time intervals in subjects with heart failure Eur J Cardiovasc Prev Rehabil 10 2003 463 468
11. Deeks J.J. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests BMJ 323 2001 157 162
12. Stroup D. Meta-analysis of observational studies in epidemiology: a proposal for reporting JAMA 283 2000 2008 2012
13. Whiting P., Rutjes A.W., and Reitsma J.B. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
14. Zamora J., Abraira V., and Muriel A. Meta-DiSc: a software for meta-analysis of test accuracy data BMC Med Res Methodol 6 2006 31
15. Egger M., Davey Smith G., and Schneider M. Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
16. Kleber F.X., Vietzke G., and Wernecke K.D. Impairment of ventilatory efficiency in heart failure: prognostic impact Circulation 101 2000 2803 2809
17. Ponikowski P., Francis D.P., and Piepoli M.F. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis Circulation 103 2001 967 972
18. Gitt A.K., Wasserman K., and Kilkowski C. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death Circulation 106 2002 3079 3084
19. Mejhert M. Ventilatory variables are strong prognostic markers in elderly patients with heart failure Heart 88 2002 239 243
20. Corrà U., Pistono M., and Mezzani A. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence Circulation 113 2006 44 50
21. Davies L. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope Eur Heart J 27 2006 684 690
22. Nanas S., Anastasiou-Nana M., and Dimopoulos S. Early heart rate recovery after exercise predicts mortality in patients with chronic heart failure Int J Cardiol 110 2006 393 400
23. Jankowska E.A., Witkowski T., and Ponikowska B. Excessive ventilation during early phase of exercise: a new predictor of poor long-term outcome in patients with chronic heart failure Eur J Heart Fail 9 2007 1024 1031
24. Guimarães G.V., Silva M.S., and d'Avila V.M. Peak VO2 and VE/VCO2 slope in betablockers era in patients with heart failure: a Brazilian experience Arq Bras Cardiol 91 2008 39 48
25. Pascual-Figal D.A., Peñafiel P., and Nicolas F. Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy Rev Esp Cardiol 61 2008 260 268
26. Frankenstein L., Nelles M., and Hallerbach M. Prognostic impact of peak VO2-changes in stable CHF on chronic beta-blocker treatment Int J Cardiol 122 2007 125 130
27. O'Neill J.O., Young J.B., and Pothier C.E. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers Circulation 111 2005 2313 2318
28. Tabet J.Y., Metra M., and Thabut G. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy Am J Cardiol 98 2006 500 503
29. Clark A.L. Origin of symptoms in chronic heart failure Heart 92 2006 12 16
30. Grieve D.A., Clark A.L., and McCann G.P. The ergoreflex in patients with chronic stable heart failure Int J Cardiol 68 1999 157 164
31. Aaronson K.D., Schwartz J.S., and Chen T.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
32. Lund L.H., Aaronson K.D., and Mancini D.M. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure Am J Cardiol 95 2005 734 741
33. Mozaffarian D., Anker S.D., and Anand I. Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 2007 392 398
34. Malfatto G., Facchini M., and Branzi G. Reverse ventricular remodeling and improved functional capacity after ventricular resynchronization in advanced heart failure Ital Heart J 6 2005 578 583
35. Doust J.A., Pietrzak E., and Dobson A. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review BMJ 330 2005 625
36. Gardner R.S., Ozalp F., and Murday A.J. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 2003 1735 1743
37. Masson S., Latini R., and Anand I.S. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
38. Passino C., Poletti R., and Bramanti F. Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure Eur J Heart Fail 8 2006 46 53
39. Levy W.C., Mozaffarian D., and Linker D.T. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433